Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sanpower Group
Manufacturing
Dendreon reinvents itself as cell therapy contract manufacturer
After surviving bankruptcy and multiple sales, Dendreon has a new focus as it looks to fill an expertise shortcoming in the market.
Kevin Dunleavy
Jun 17, 2021 10:35am
Sanpower hands off Dendreon in $868M deal, its 3rd sale in 3 years
Aug 3, 2018 11:34am
Dendreon aims for 10% Provenge growth—and a CAR-T buy
Apr 2, 2018 10:36am
FiercePharmaAsia: Astellas, Takeda, Sanpower and more
Jan 20, 2017 7:54am
Sanpower takes on expensive Provenge manufacturing with Dendreon deal
Jan 17, 2017 8:45am
